Blog
RSS FeedPosted by Michael Wonder on 15 May 2020
A drug company wagers the U.S. won’t dare charge it with crimes
15 May 2020 - Teva, the world’s largest maker of generic drugs, recently pulled out of settlement talks with the Justice ...
Posted by Michael Wonder on 08 May 2020
The pandemic is a chance to revamp India’s pharmaceutical industry
9 May 2020 - Companies could switch from primarily making generics to producing higher-margin licensed drugs. ...
Posted by Michael Wonder on 06 May 2020
Medicines Australia joins forces with 15 health care organisations to highlight continuity of care
6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...
Posted by Michael Wonder on 26 Apr 2020
Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies
26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...
Posted by Michael Wonder on 24 Apr 2020
Drug makers prepare to make coronavirus treatments
23 April 2020 - Preparations would help make doses rapidly if testing pans out, but companies risk large outlays if the ...
Posted by Michael Wonder on 21 Apr 2020
Coronavirus puts big pharma’s IP regime to the test
21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...
Posted by Michael Wonder on 21 Apr 2020
If pharma helps quench the COVID-19 pandemic, what will it want in return?
21 April 2020 - Make no mistake: the only long-term solution to the COVID-19 pandemic is a safe and effective ...
Posted by Michael Wonder on 20 Apr 2020
Big pharma has the chance to come to the world’s rescue
20 April 2020 - The pandemic may finally do for the pharmaceutical industry what relentless TV advertising cannot: show off its ...
Posted by Michael Wonder on 18 Apr 2020
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
17 April 2020 - The National Institutes of Health (NIH) and the Foundation for the NIH are bringing together more than ...
Posted by Michael Wonder on 16 Apr 2020
Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19
16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...
Posted by Michael Wonder on 15 Apr 2020
Vaccine development becomes reality TV. Can it make viewers rethink pharma?
14 April 2020 - The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it ...
Posted by Michael Wonder on 15 Apr 2020
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
14 April 2020 - Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to ...
Posted by Michael Wonder on 14 Apr 2020
Vaccine development is a case of 'market failure'
13 April 2020 - Reliance on the private market to develop vaccines has failed, leaving us vulnerable to pandemics such as ...
Posted by Michael Wonder on 08 Apr 2020
Pharmaceutical profits and public health are not incompatible
8 April 2020 - We need the capital and creativity of the private sector to take on the coronavirus. ...
Posted by Michael Wonder on 07 Apr 2020
Global plasma leaders collaborate to accelerate development of potential COVID-19 hyperimmune therapy
6 April 2020 - Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the ...